Revised ANVISA guidelines encourage development of biologics and biosimilars in Brazil in response to an increasing demand for development there. Since 2002, the Agência Nacional de Vigilância ...
To help drug manufacturers comply with the technical requirements of RCD 753/2022 and other related standards regarding proof of a drug’s safety and efficacy, Brazil’s Anvisa issued three new ...
SAN DIEGO, Dec. 5, 2019 /PRNewswire/ -- Medical Marijuana, Inc. ("the Company") (OTC: MJNA), the first-ever publicly traded cannabis company in the United States that launched the world's first-ever ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback